Patents by Inventor Tadas Panavas

Tadas Panavas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Humanized anti-CD200 antibodies and uses thereof
    Patent number: 11802154
    Abstract: Provided herein are antibodies, or antigen binding portions thereof, that bind to CD200. Also provided are uses of these proteins in therapeutic applications, such as the treatment of cancer and in conjunction with organ transplantation. Also provided are nucleic acids encoding the heavy and/or light chain variable regions (or heavy and/or light chains) of the antibodies, vectors comprising the nucleic acids, and cells that produce the antibodies.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: October 31, 2023
    Assignee: Alexion Pharmaceuticals, Inc.
    Inventors: Taneisha Ann-Tanara Mack, Douglas L. Sheridan, Tadas Panavas
  • HUMANIZED ANTI-CD200 ANTIBODIES AND USES THEREOF
    Publication number: 20210230273
    Abstract: Provided herein are antibodies, or antigen binding portions thereof, that bind to CD200. Also provided are uses of these proteins in therapeutic applications, such as the treatment of cancer and in conjunction with organ transplantation. Also provided are nucleic acids encoding the heavy and/or light chain variable regions (or heavy and/or light chains) of the antibodies, vectors comprising the nucleic acids, and cells that produce the antibodies.
    Type: Application
    Filed: December 20, 2018
    Publication date: July 29, 2021
    Inventors: Taneisha Ann-Tanara MACK, Douglas L. SHERIDAN, Tadas PANAVAS
  • Methods and compositions for enhanced protein expression and purification
    Patent number: 8691958
    Abstract: Methods for enhancing expression levels, secretion, and purification of heterologous fusion proteins in a host cell are disclosed.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: April 8, 2014
    Assignees: Progenra, Inc., Lifesensors, Inc.
    Inventors: Tauseef R. Butt, Tadas Panavas, Amolkumar Karwa, Raymond J. Peroutka, Jeffrey G. Marblestone
  • Methods and Compositions for Enhanced Protein Expression and Purification
    Publication number: 20120065106
    Abstract: Methods for enhancing expression levels, secretion, and purification of heterologous fusion proteins in a host cell are disclosed.
    Type: Application
    Filed: December 28, 2007
    Publication date: March 15, 2012
    Applicant: LIFESENSORS, INC.
    Inventors: Tauseef R. Butt, Tadas Panavas, Amolkumar Karwa, Raymond J. Peroutka, Jeffrey G. Marblestone